Micronoma logo — Saving patient lives with a minimally-invasive, cancer scree...

Micronoma

Saving patient lives with a minimally-invasive, cancer screening test.

Founded 2019 United States San Diego, United States 5 employees Convertible Note Total: $17.50M Biotechnology, Health Care +1

General Information

Company Name Micronoma
Founded Year 2019
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 5
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Micronoma. To contact Micronoma, visit micronoma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Micronoma

Micronoma is a biotechnology startup based in San Diego, California that holds the promising slogan of "Saving patient lives with a minimally-invasive, cancer screening test." Established in 2019, the company pioneers cancer detection through liquid biopsy technology, utilizing microbial signals for accurate and early-stage cancer detection and prediction. With a strong foundation in microbiome research, Micronoma aspires to revolutionize cancer diagnosis and improve patient outcomes. Notably, Micronoma recently secured an $11.00M Convertible Note investment on 31 March 2022, further testament to the company's potential advancements in the realm of cancer diagnostics. This venture illustrates the growing interest and investment in innovative healthcare solutions, particularly those that aim to enhance early-stage cancer detection and ultimately save lives.

Taxonomy: cancer screening, liquid biopsy, microbial signal, early cancer detection, minimally-invasive, microbiome research, clinical-grade accuracy, San Diego

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note $11.00M -
31 Mar 2022
Convertible Note $3.50M 2
Symbiosis LLC, Seerave Foundation
17 Feb 2021
Seed Round $3.00M 1
Symbiosis LLC
12 Aug 2020

Micronoma Alternatives & Competitors

View All Alternatives
Micronoma vs

The Future of Cancer Diagnostics

Series A
24 employees
Biotechnology, Health Care
Micronoma vs

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions

Venture round
Biotechnology, Health Care
Micronoma vs
VisionGate, Inc.
VisionGate, Inc. United States

Leading the Battle Against Lung Cancer through our Early Detection Technology

Venture round
24 employees
Biotechnology, Health Care

FAQ About Micronoma

Saving patient lives with a minimally-invasive, cancer screening test.
Micronoma was founded in 2019.
Micronoma is headquartered in San Diego, United States.
Micronoma operates in Biotechnology, Health Care and Life Sciences. Its work centres on cancer screening, liquid biopsy, microbial signal and early cancer detection.
Micronoma has approximately 5 employees.
Micronoma has completed 3 funding rounds, raising a total of $17.50M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Micronoma include Dxcover, Thrive Earlier Detection, VisionGate, Inc., Nucleix Ltd., ANCON Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Micronoma and Dxcover are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Micronoma, https://bouncewatch.com/company/micronoma, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes